Real-time electrochemical recording of dopamine release under optogenetic stimulation

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Chiu, Wen Tai ^a   Lin, Che Ming ^a   Tsai, Tien Chun ^a   Wu, Chun Wei ^a   Tsai, Ching Lin ^b   Lin, Sheng Hsiang ^a   Chen, Jia Jin Jason ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c NATIONAL APPLIED RESEARCH LABORATORIES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; DOPAMINE; NIFEDIPINE; RHODOPSIN; CALCIUM; CHANNELRHODOPSIN 2, RAT; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN;

AMPEROMETRY; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL SPECIFICITY; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; ELECTROCHEMICAL DETECTION; EXOCYTOSIS; MICROELECTRODE; NERVE CELL STIMULATION; NONHUMAN; OPTOGENETICS; RAT; SINGLE CELL ANALYSIS; ANIMAL; ELECTROCHEMICAL ANALYSIS; GENETIC PROCEDURES; GENETICS; METABOLISM; PC12 CELL LINE; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; BIOSENSING TECHNIQUES; CALCIUM; DOPAMINE; ELECTROCHEMICAL TECHNIQUES; EXOCYTOSIS; GREEN FLUORESCENT PROTEINS; MICROELECTRODES; OPTOGENETICS; PC12 CELLS; RATS; RHODOPSIN;

EID: 84895870527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089293     Document Type: Article

References (40)

1. Morikawa H, Paladini CA (2011) Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms. Neuroscience 198: 95-111.
2. Speelman AD, van de Warrenburg BP, van Nimwegen M, Petzinger GM, Munneke M, etal. (2011) How might physical activity benefit patients with Parkinson disease? Nat Rev Neurol 7: 528-534.
3. Hallett M (2012) Parkinson's disease tremor: pathophysiology. Parkinsonism & Relat Disord 18: S85-S86.
4. Romito LM, Albanese A (2010) Dopaminergic therapy and subthalamic stimulation in Parkinson's disease: a review of 5-year reports. J Neurol 257: S298-S304.
5. Zhang M, Lee HJ, Park KH, Park HJ, Choi HS, etal. (2012) Modulatory effects of sesamin on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells. Neuropharmacology 62: 2218-2225.
6. Hondebrink L, Meulenbelt J, Meijer M, van den Berg M, Westerink RH (2011) High concentrations of MDMA ('ecstasy') and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells. Neuropharmacology 61: 202-208.
7. Perry SW, Barbieri J, Tong N, Polesskaya O, Pudasaini S, etal. (2010) Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. J Neurosci 30: 14153-14164.
8. Uezato T, Sato E, Miura N (2012) Screening of natural medicines that efficiently activate neurite outgrowth in PC12 cells in C2C12-cultured medium. Biomed Res 33: 25-33.
9. Lassiter TL, MacKillop EA, Ryde IT, Seidler FJ, Slotkin TA (2009) Is fipronil safer than chlorpyrifos? Comparative developmental neurotoxicity modeled in PC12 cells. Brain Res Bull 78: 313-322.
10. Xu F, Chang X, Lou D, Wu Q, Zhou Z (2012) Chlorpyrifos exposure causes alternation in dopamine metabolism in PC12 cells. Toxicol Mech Methods 22: 309-314.
11. Deng C, Tao R, Yu SZ, Jin H (2012) Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner. Mol Med Rep 5: 847-851.
12. Zhu TG, Wang XX, Luo WF, Zhang QL, Huang TT, etal. (2012) Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action. Neurosci Lett 506: 175-179.
13. Yoshida H, Date I, Shingo T, Fujiwara K, Kobayashi K, etal. (2003) Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study. J Neurosurg 98: 874-881. (Pubitemid 36401552)
14. Lindvall O, Wahlberg L (2008) Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease? Exp Neurol 209: 82-88.
15. Tatard VM, Venier-Julienne MC, Benoit JP, Menei P, Montero-Menei CN (2004) In vivo evaluation of pharmacologically active microcarriers releasing nerve growth factor and conveying PC12 cells. Cell Transplant 13: 573-583. (Pubitemid 39557436)
16. Kobayashi K, Yasuhara T, Agari T, Muraoka K, Kameda M, etal. (2006) Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat. Brain Res 1102: 1-11. (Pubitemid 44092662)
17. Xia R, Berger F, Piallat B, Benabid AL (2007) Alteration of hormone and neurotransmitter production in cultured cells by high and low frequency electrical stimulation. Acta Neurochir 149: 67-73. (Pubitemid 46090192)
18. Opler M, Rukenstein A, Cote L, Goodman R (1997) Reduced dopamine levels in PC12 cells exposed to low frequency electromagnetic fields. Bioelectrochem Bioenerg 42: 235-239. (Pubitemid 27273853)
19. Kravitz AV, Freeze BS, Parker PR, Kay K, Thwin MT, etal. (2010) Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466: 622-626.
20. Nagel G, Szellas T, Huhn W, Kateriya S, Adeishvili N, etal. (2003) Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A 100: 13940-13945. (Pubitemid 37499170)
21. Tsai HC, Zhang F, Adamantidis A, Stuber GD, Bonci A, etal. (2009) Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324: 1080-1084.
22. Bass CE, Grinevich VP, Vance ZB, Sullivan RP, Bonin KD, etal. (2010) Optogenetic control of striatal dopamine release in rats. J Neurochem 114: 1344-1352.
23. Meyer JH (2012) Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention. Clin Pharmacol Ther 91: 201-214.
24. Bazzu G, Calia G, Puggioni G, Spissu Y, Rocchitta G, etal. (2010) alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach. CNS Neurol Disord Drug Targets 9: 482-490.
25. Wei D, Bailey MJ, Andrew P, Ryhanen T (2009) Electrochemical biosensors at the nanoscale. Lab Chip 9: 2123-2131.
26. Hsueh CC, Brajter-Toth A (1994) Electrochemical preparation and analytical applications of ultrathin overoxidized polypyrrole films. Anal Chem 66: 2458-2464.
27. Xiao YH, Guo CX, Li CM, Li YB, Zhang J, etal. (2007) Highly sensitive and selective method to detect dopamine in the presence of ascorbic acid by a new polymeric composite film. Anal Biochem 371: 229-237. (Pubitemid 350015965)
28. Dalmia A, Liu CC, Savinell RF (1997) Electrochemical behavior of gold electrodes modified with self-assembled monolayers with an acidic end group for selective detection of dopamine. J Electroanal Chem 430: 205-214. (Pubitemid 127378935)
29. Malem F, Mandler D (1993) Self-assembled monolayers in electroanalytical chemistry: application of.omega.-mercapto carboxylic acid monolayers for the electrochemical detection of dopamine in the presence of a high concentration of ascorbic acid. Anal Chem 65: 37-41. (Pubitemid 23037524)
30. Qiu HJ, Zhou GP, Ji GL, Zhang Y, Huang XR, etal. (2009) A novel nanoporous gold modified electrode for the selective determination of dopamine in the presence of ascorbic acid. Colloids Surf B Biointerfaces 69: 105-108.
31. Kumar SS, Mathiyarasu J, Phani KL (2005) Exploration of synergism between a polymer matrix and gold nanoparticles for selective determination of dopamine. J Electroanal Chem 578: 95-103. (Pubitemid 40423658)
32. Shafer TJ, Atchison WD (1991) Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 12: 473-492.
33. Chen Y, Guo C, Lim L, Cheong S, Zhang Q, etal. (2008) Compact microelectrode array system: tool for in situ monitoring of drug effects on neurotransmitter release from neural cells. Anal Chem 80: 1133-1140. (Pubitemid 351278387)
34. Abu-Raya S, Bloch-Shilderman E, Lelkes PI, Trembovler V, Shohami E, etal. (1999) Characterization of pardaxin-induced dopamine release from pheochromocytoma cells: role of calcium and eicosanoids. J Pharmacol and Exp Ther 288: 399-406. (Pubitemid 29119644)
35. Ishizuka T, Kakuda M, Araki R, Yawo H (2006) Kinetic evaluation of photosensitivity in genetically engineered neurons expressing green algae lightgated channels. Neurosci Res 54: 85-94. (Pubitemid 43112092)
36. Chang YF, Arai Y, Nagai T (2012) Optogenetic activation during detector "dead time" enables compatible real-time fluorescence imaging. Neurosci Res 73: 341-347.
37. Saito K, Chang YF, Horikawa K, Hatsugai N, Higuchi Y, Hashida M, etal. (2012) Luminescent proteins for high-speed single-cell and whole-body imaging. Nat Commun 3: 1262.
38. 2+ indicators. Science 333: 1888-1891.
39. Akerboom J, Carreras CN, Tian L, Wabnig S, Prigge M, etal. (2013) Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics. Front Mol Neurosci 6: 2.
40. 2+ indicators and photophysical considerations for optogenetic applications. ACS Chem Neurosci 4: 963-972.